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The phosphorylation of a-crystallin B was studied in homogenates of autopsy samples of brain tissue from patients with Alexander’s disease, a 
condition characterized by over-expression of this protein. After incubation in the presence of [y-32P]ATP and CAMP the homogenates were 
analyzed by two-dimensional clectrophorcsis, (isoelectric focusing followed by SDS-PAGE). Three major polypeptides having the same molecular 
weight as bovine lens a-crystallin B and ~1s 7.1, 6.9 and 6.7 were detected in the Coomassie blue stained gels. These three polypeptides were 
recognized by an a-crystallin B-specific antiserum in Western blots. The polypeptides with pls 7.1 and 6.7 co-migrated in isoelectric focusing gels 
with bovine lens aB and its phosphorylatcd form aBp, respectively. Radioautography of the two-dimensional gels demonstrated the presence of 
12P in the most acidic polypeptide. The results demonstrate the occurrence of aB phosphorylation in Alexander’s disease brain tissue. 
Lens protein; Protein phosphorylation; Alpha crystallin; Alexander’s disease 
1. INTRODUCTION 
The crystallins are a family of proteins present at very 
high concentrations in the eye lens where they account 
for 20-60% of the wet weight of the tissue. Whereas 
some crystallins are specialized lens proteins, other ap- 
pear to be cellular enzymes which are expressed specifi- 
cally at very high levels in the lens but are also present 
in other tissues [1,2]. a.-Crystallin, a major crystallin 
found in the lens of all vertebrates, is a highly conserved 
protein related to the small heat shock proteins [3-51. 
It is composed of 2 polypeptide chains, aA and aB, of 
approximately 20 000 Da, each of which is the product 
of a different gene and which share 57% a&no acid 
homology [1,4]. Whereas aA is exclusively expressed in 
the lens, aB is also expressed in a variety of other tissues 
[C-13]. 
gates appear to be localized specifically at the myofibri- 
lar z-lines, where they are thought to play a structural 
or protective role [20]. 
Though little is understood about a-crystallin func- 
tion, it is now clear that phosphorylation at specific 
serine residues accounts for the major post-translational 
modification of both aA and aB polypeptides in the lens 
in vivo [21-241. These phosphorylations are apparently 
regulated by CAMP and seem to be reversible since 
phosphorylated aA can be dephosphorylated in lens 
epithelial cell extracts by a endogenous calcium/&lmo- 
dulin-dependent phosphoprotein phosphatase [25]. 
The normal functions of a-crystallin B are poorly 
understood. In the lens, a-crystallin B is believed to be 
present in large aggregates of 800 000 Da composed of 
both A and B polypeptides [14,15]. These aggregates, 
ordered and densely packed in the cytoplasm of the lens 
fiber cells, are thought to be responsible for the transpa- 
rency and refractive power of the tisse [16-181. In non- 
lenticular tissues, such as brain and cardiac muscle, crB 
also appears to occur in aggregates imilar in size to 
those in the lens [19]. In cardiac myocytes, these aggre- 
Compared to the lens, normal non-lenticular tissues 
express very low levels of aB. However, under certain 
pathologic onditions, the expression of this protein can 
be enhanced. Increased aB expression occurs particu- 
larly in the brain of patients with Alexander’s disease 
[9,26], but also in some glial tumors and scars, and in 
scrapie-infected hamsters [2]. Alexander’s disease is a 
degenerative disorder primarily affecting children, and 
characterized by loss of (or lack of) myelin in the CNS 
and the presence of large numbers of inclusions known 
as Rosenthal fibers [27]. These inclusions, which occur 
in astrocytes throughout the brain, are composed of 
granular deposits associated with intermediate fila- 
ments. aB represents the major component of Rosen- 
thal fibers [9,28]. 
*An abstract of this work was presented at the 1990 American Society 
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Although aB phosphorylation in the lens has been 
studied to a certain extent, the phosphorylation of this 
polypeptide in non-lenticular tissues has not been exam- 
ined. Since Alexander’s disease brain tissue expresses 
high levels of ccB, experiments were conducted to deter- 
mine whether this protein undergoes phosphorylation 
in this tissue as it occurs in the normal lens. 
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2. MATERIALS AND METHODS 
Alexander’s disease brain tissue was obtained postmortem and 
stored at -70°C. Approximately 50 mg of tissue was minced and then 
disrupted gently in a ground glass homogcnizcr in 0.5 ml of a buffer 
solution containing 20 mM MOPS, pH 7.6, 20 mM ATP, 20 mM 
MgCl,, 20,~M CAMP and 4 mM NaF. This reaction mixture contain- 
ing Alexander’s disease brain homogenate, cAMP and ATP was in- 
cubated at 37°C. The reaction was started by adding 10~1 of50$Jiiml 
[y-‘2P]ATP to the mixture and stopped after 0 and 2 h by precipitation 
with 10% trichloroacctic acid at 0°C. The protein precipitates were 
collected by centrifugation at 12 000 x g for 15 min. The pellets were 
washed three times with 95% ethanol and once with anhydrous diethyl 
ether, dried and then analyzed by two-dimensional gel electrophoresis 
(2-D gels) i.e. isoelectric focusing under denaturing conditions (IEF) 
followed by sodium dodecyl sulfate polyacrylamide gel elcctrophoresis 
(SDS-PAGE). IEF gels were performed as previously described [29] 
and contained 2.4% Ampholine pH 5 8, 0.6% Ampholine pH 3.5 IO 
(Pharmacia-LKB) and 6 M urea. Samples were applied in a solution 
containing 6 M urea and 0.1% 2-mercaptoethanol. For the second 
dimension, SDS-PAGE was performed according to the procedure 
described by Laemmli [30] in an 8-18% polyacrylamide gradient gel. 
The gels were stained with Coomassie blue, dried onto filter paper and 
exposed for autoradiography. Western blots were performed by trans- 
ferring protein from IEF gels onto PVDF membrane (Immobilon P, 
Millipore). After the blocking with a 0.05% solution of Twecn 20 in 
phosphate buffered saline (TPBS) containing 3% bovine serum al- 
bumin (BSA) for 30 min, the membrane was incubated with an anti 
a-crystallin antiserum at a I:500 dilution in BSAiTPBS for 60 min. 
This polyclonal antiserum, #23. I, raised in rabbits against otal bovine 
a-crystallin (0.X x lOh Da aggregate) isolated from lens fiber cells is 
specific for a-crystallin and recognizes both the aA and the aB poly- 
peptides of the bovine and rat lens protein [3l]. The blots were visual- 
ized with horseradish peroxidase conjugated goat anti-rabbit IgG 
using a kit from Bio-Rad. 
3. RESULTS AND DISCUSSION 
Fig. 1 illustrates a Coomassie blue stained gel of Alcx- 
ander’s disease brain homogenate fractionated by 2-D 
gel electrophoresis. Three major polypeptides having 
the same apparent molecular mass (M,) as bovine lens 
a-crystallin B (i.e., approximately 22 000) and pIs of 
7.1, 6.9, and 6.7 were resolved. These 3 polypeptides 
were recognized in Western blots by a rabbit antiserum 
against total bovine a-crystallin (Fig. 2), and by a rabbit 
IEF - 
6.7 7.1 
Fig. I. Two-dimensional gel electrophoresis analysis of Alexander’s 
disease brain homogenate. A Coomassie blue stained gel is shown 
demonstrating 3 major polypeptide species (arrows) with M, of ap- 
proximately 22 000 and pIs of 7.1, 6.9 and 6.7. 
antiserum against a-crystallin B from rat cardiac muscle 
[l 11. The polypeptides present in the Alexander’s dis- 
ease brain homogenate with pls 7.1 and 6.7 co-migrated 
‘with bovine clB and its phosphorylatcd form, aB,,, re- 
spectively (Fig. 2). Similar Western blot analysis of nor- 
mal human brain homogenates using the same antisera 
demonstrated the same polypeptidc pattern, i.e. 3 major 
22 000 Da polypeptides with pls of 7. I, 6.9, and 6.7 (not 
shown). However, given the very low levels of aB in 
normal brain, it was necessary to increase the amount 
of protein loaded into the gels approximately 20-fold, 
and to use a more sensitive alkaline phosphatase system 
to detect the polypeptides. 
Coomassie blue-stained gels of a phosphorylation 
reaction mixture containing Alexander’s disease brain 
homogenate, [y-‘2P]ATP and CAMP, incubated for 0 
and 2 h, both showed the 2 species (~1s 6.9 and 6.7) 
more acidic than the unphosphorylated aB (PI 7.1), 
(Fig. 3A and B). However, autoradiography of the 2-D 
gels (Fig. 3C) demonstrated that after 2 h incubation 
only the most acidic polypeptide with a pl of 6.7 was 
labelled with “P. This polypeptide with pI 6.7 co-migra- 
ted with the in vivo phosphorylated bovine a-crystallin 
B, crB, (Fig. 2) and corresponds to the form of dB which 
is phosphorylated at a single site [23-321. There is no 
evidence, however, that the polypeptide with pI 6.9 is 
a phosphorylated form of the CZB. Thie polypeptide 
must, therefore, be a product of another type of post- 
translational modification. 
The finding in Alexander’s disease brain tissue (and 
in normal human brain tissue as well) of a polypeptide 
with M, and p1 indistinguishable from those of lens 
&BP, which is recognized by an antibody specific for 
bovine lens cl-crystallin B, indicates that the phosphor- 
ylated form of olB indeed occurs in human brain in vivo. 
In addition, the results of the in vitro 12P incorporation 
experiments demonstrate the presence of aB phosphor- 
uAp 
CtA 
aBP 
CXB 
,- 
AB 
- 6.7 
- 6.9 
- 7.1 
Fig, 2. Western blot analysis of the Alexander’s disease brain homoge- 
nate after separation by flat bed IEF. A rabbit serum anti-bovine lens 
a-crystallin was used. (A) a-crystallin from bovine lens fiber cells 
(approximately 0.2 pg of total protein). (B) Alexander’s disease brain 
homogenate (approximately lO/~g of total protein). Three species with 
~1s 7.1, 6.9 and 6.7 in the homogenate were recognized by the anti- 
serum. The species with pIs of 7.1 and 6.7 co-migrate with bovine aB 
and its phosphorylated form aBp, respectively. 
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Fig. 3. Two-dimensional gel electrophorcsis analysis of a reaction 
mixture containing Alexander’s disease brain homogenate, ATP and 
CAMP, incubated for 0 h (A) and 2 h (B and C). The relevant areas 
of the Coomassie blue stained gels are shown in A and B. The autora- 
diogram of the gel in B is shown in C. The arrows in A and B indicate 
aB (pl 7.1) and its phosphorylated form aBp (p1 6.7). The arrow in 
panel C indicates clBp (pl 6.7). Incubation for 2 h in the presence of 
[y12P]ATP and CAMP results in ‘ZP-labelling of dBp, the most acidic 
polypeptide. 
ylation pathway(s) in this tissue. A more acidic form of 
aB, comparable to the lens aB,, has been observed in 
mouse and bovine heart extracts [32]. Thus, the phos- 
phorylation of aB appears to be a normal feature of 
non-lenticular tissues, including the normal human 
brain. 
In normal tissues, protein phosphorylation generally 
serves the purpose of regulating the function of proteins 
[33]. However, the role of a-crystallin B phosphoryla- 
tion in normal tissues including the lens remains un- 
known. In normal rat tissues such as brain and cardiac 
muscle, the native aB is present in large aggregates 
(800 000 Da) similar in size to those of lens a-crystallin 
[19]. In cardiac myocytes, these aggregates appear to 
interact with the cytoskeletal filaments of the myofibri- 
lar z-lines [20]. Perhaps phosphorylation modulates the 
normal interactions of aB polypeptides among them- 
selves or with cytoskeletal structures in the brain tissue. 
The significance of a-crystallin B phosphorylation in 
the pathogenesis of Alexander’s disease is uncertain. 
Disturbance of the phosphorylation of tau proteins, a 
family of developmentally regulated proteins that stabi- 
lize the microtubule network, has been demonstrated in 
the brain of heat-shocked rats [35], and appears to be 
a contributing factor in the formation of neurofibrillary 
tangles, a characteristic neuropathological esion of 
Alzheimer’s disease [34]. It is then possible that abnor- 
malities in aB phosphorylation may affect the interac- 
tions of these polypeptides with cytoskeletal structures 
in the brain, and in this manner contribute to the forma- 
tion of the Rosenthal fibers. However, the aB polypep- 
tide pattern observed in Western blots of Alexander’s 
disease brain was not significantly different from that 
of the normal human brain. The 3 major olB polypepti- 
des of pls 7.1,6.9 and 6.7 were present in both patholo- 
gical and normal tissue. Therefore, qualitative abnor- 
malities in aB phosphorylation apparently are not relat- 
ed to the formation of Rosenthal fibers. 
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